|
Parameter
|
Variable
|
Specification
|
Number (percentage)
|
p-value
|
|---|
|
PPS 2011
|
PPS 2016
|
|---|
|
Antimicrobial prescriptions (all)
| | |
14,076 (100)
|
22,086 (100)
|
n.a.
|
|
Linezolid prescriptions (all)
| | |
119 (0.8)
|
255 (1.2)
|
< 0.01
|
|
Linezolid prescriptions (all wards)
|
Total
| |
119 (100)
|
255 (100)
|
n.a.
|
|
Dosage
|
2 × 600 mg
|
n.a.
|
227 (89.0)
|
n.a.
|
|
All other dosages
|
n.a.
|
28 (11.0)
|
|
Route of application
|
Parenteral
|
87 (73.1)
|
179 (70.2)
|
0.57
|
|
Oral
|
32 (26.9)
|
76 (29.8)
|
|
Linezolid prescriptions in non-ICU wards
|
Total
| |
67 (56.3)
|
156 (61.2)
|
n.a.
|
|
Route of application
|
Parenteral
|
36 (53.7)
|
87 (55.8)
|
0.78
|
|
Oral
|
31 (46.3)
|
69 (44.2)
|
- P-values for variables were calculated using Chi-squared test. Bold print is used to indicate statistical significance. Abbreviations: PPS point prevalence survey, ICU intensive care unit, n.a. not available/not applicable
